ERBB2 and gastric cancer: In Her2-positive gastric cancer, Lin et al. demonstrated that a bispecific antibody targeting PD-1 and Her2 (IBI315) not only enhanced antitumor immunity but also induced GSDMB-mediated pyroptosis in tumor cells.